There were 209 patients included in the study; 103 received the ProDisc and 106 underwent ACDF. The seven-year follow-up rate was 92 percent — 152 of 165 patients. Here are five key findings.
1. The procedures were both effective introducing neck and arm pain as well as improving and maintaining function and health-related quality of life.
2. Around 88 percent of the ProDisc-C patients maintained or improved neurologic status; 89 percent of the ACDF patients reported the same.
3. At the seven-year mark, patients reported 30 secondary surgical procedures performed in 106 of the patients in the ACDF group and seven of the 103 patients in the ProDisc-C group.
4. There weren’t significant differences in device-related adverse events between the groups.
5. The researchers concluded ProDisc-C patients had lower risk for additional surgeries, “suggesting that total disc arthroplasty provides durable results and has the potential to slow the rate of adjacent-level disease,” concluded the study authors.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
